In this work we observed a strong anti-inflammatory effect of Omegaven® on human monocytes activated by LPS, nearly suppressing IL-6, IL-8, IL-1β and TNFα whose elevated levels have been associated previously with NASH and liver fibrosis [28]. Here, IL6 is linked to metabolic dysfunction-associated steatohepatitis.